Concepción García

Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson's disease

Yolanda Gómez‐Gálvez, Cristina Palomo‐Garo, Javier Fernández‐Ruíz et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2015 · 213 citations

Medicine, Neuroscience, Pharmacology +14

Symptom‐relieving and neuroprotective effects of the phytocannabinoid Δ⁹‐THCV in animal models of Parkinson's disease

Concepción García, Cristina Palomo‐Garo, Moisés Garcı́a-Arencibia et al. · British Journal of Pharmacology · 2011 · 208 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Different Susceptibility to the Parkinson's Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1

Nadia G. Innamorato, Agnieszka Jaźwa, Ana I. Rojo et al. · PLoS ONE · 2010 · 140 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors

Francisco Espejo‐Porras, Javier Fernández‐Ruíz, Roger G. Pertwee et al. · Neuropharmacology · 2013 · 74 citations

Medicine, Neuroscience, Pharmacology +13

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor

Concepción García, María Gómez‐Cañas, Sonia Burgaz et al. · Journal of Neuroinflammation · 2018 · 64 citations · Full text

Medicine, Neuroscience, Pharmacology +17